Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion type Assertion NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_head.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion description "[High HOXB13-to-IL17BR ratio expression levels associate with both tumor aggressiveness and tamoxifen therapy failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_provenance.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion evidence source_evidence_literature NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_provenance.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion SIO_000772 17308270 NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_provenance.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion wasDerivedFrom befree-20140225 NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_provenance.
- NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_assertion wasGeneratedBy ECO_0000203 NP502202.RAddVliF3vX7F-u6AUxrNJvAJFVXeocBjByGHroe7_j4w130_provenance.